Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats

Psychopharmacology

Volumn 148, Issue 2, 2000, Pages 209-216

  Munzar, Patrik ^a   Goldberg, Steven R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

7 OH DPAT; Bupropion; Chloro APB; Chloro PB; cis Flupenthixol; Cocaine; Dopamine; Drug discrimination; GBR 12909; Methamphetamine; Nomifensine; NPA; Rat; SCH 23390; Spiperone

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMFEBUTAMONE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; FLUPENTIXOL; METHAMPHETAMINE; NOMIFENSINE; SODIUM CHLORIDE; SPIPERONE; VANOXERINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISCRIMINATIVE STIMULUS; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; DRUG DISCRIMINATION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033961891     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050044     Document Type: Article

References (27)

1. 3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. Eur J Pharmacol 358:101-109
2. Brauer LH, Goudie AJ, de Wit H (1997) Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology 130:2-13
3. 2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 103: 50-55
4. 2 receptors in mediating the d-amphetamine discriminative cue. Eur J Pharmacol 202:191-199
5. 1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur J Pharmacol 246:39-44
6. Kuczenski R, Segal DS, Cho AK, Melega W (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-1317
7. Levant B (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252
8. 11C]WIN-35,428. J Neurosci 18:8417-8422
9. Melega WP, Williams AE, Schmitz DA, DiStefano EW, Cho AK (1995) Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274:90-96
10. Munzar P, Goldberg SR (1999) Noradrenergic modulation of the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 143:293-301
11. 3 receptor antagonist thioperamide in rats. Eur J Pharmacol 363:93-101
12. Munzar P, Baumann MH, Shoaib M, Goldberg SR (1999a) Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology 141:287-296
13. Munzar P, Laufert MD, Kutkat SW, Nováková J, Goldberg SR (1999b) Effects of various serotonin agonists, antagonists and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther 291:239-250
14. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC
15. Nielsen EB, Randrup K, Andersen PH (1989) Amphetamine discrimination: effects of dopamine receptor agonists. Eur J Pharmacol 160:253-262
16. Sasaki JE, Tatham TA, Barrett JE (1995) The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology 120:303-310
17. Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR (1999) Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371:123-135
18. Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270:1041-1048
19. Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174
20. Van Groll BJ, Appel JB (1992) Stimulus effects of d-amphetamine 1: DA mechanisms. Pharmacol Biochem Behav 43:967-973
21. Varty GB, Higgins GA (1997) Investigation into the nature of a 7-OH-DPAT discriminative cue: comparison with d-amphetamine. Eur J Pharmacol 339:101-107
22. Weed MR, Paul IA, Dwoskin LP, Moore SE, Woolverton WL (1997) The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys. J Pharmacol Exp Ther 283:29-38
23. Weed MR, Woolverton WL, Paul IA (1998) Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata. Eur J Pharmacol 361:129-142
24. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703
25. Witkin JM, Savtchenko N, Mashkovsky M, Beekman M, Munzar P, Gasior M, Goldberg SR, Ungard JT, Kim J, Shippenberg T, Chefer V (1999) Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine. J Pharmacol Exp Ther 288: 1298-1310
26. Yasar S, Schindler CW, Thorndike EB, Szelenyi I, Goldberg SR (1993) Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats. J Pharmacol Exp Ther 265:1-6
27. Yasar S, Schindler CW, Thorndike EB, Goldberg SR (1994) Evaluation of deprenyl for cocaine-like discriminative stimulus effects in rats. Eur J Pharmacol 259:243-250